Washington, DC—(ENEWSPF)—April 16, 2014. Pharmaceutical company Astellas Pharma US Inc. will pay $7.3 million to resolve allegations that it violated the False Claims Act in connection with its marketing and promotion of the drug Mycamine for pediatric use, the Justice Department announced today. Astellas Pharma US Inc., located in Northbrook, Ill., manufactures and sells pharmaceutical drugs, including Mycamine.
“The FDA’s drug approval process requires companies to demonstrate the safety and efficacy of their products,” said…
